Formulators Increasingly Specify Documented Premix Bioavailability Data
Retail and government-procurement buyers increasingly specify documented premix bioavailability and stability validation data directly within procurement briefs, citing genuine regulatory and public-health scrutiny demand that undocumented commodity-grade sourcing cannot credibly address across scaled global distribution. This specification trend has become a stronger development catalyst than general cost marketing alone in several major fortification categories recently. Suppliers who developed standardized bioavailability documentation early now command meaningfully stronger positioning than competitors still confined to undocumented commodity-grade supply. Buyer trust in this category keeps compounding as documentation track records lengthen across retail and government-procurement channels globally.
Market Impact: Lifts demand by 13 pct








